Introduction
The RHOA-Rho kinase (ROCK1/2) signalling pathway is associated with multiple cardiovascular, metabolic, and neurodegenerative diseases, and cancer. 1 RHOA is a member of a family of small GTPases that, together with downstream effector kinases ROCK1 and ROCK2, acts as a molecular switch regulating processes like cell migration, cytoskeletal reorganization, and gene transcription. 1, 2 RHOA-ROCK signalling is also been linked to early cardiogenesis and embryonic left-right asymmetry. [3] [4] [5] [6] In addition, the function of the cardiac conduction system (CCS) likely depends on RHOA-ROCK signalling since (i) adult mice with altered RHOA expression present with bradycardia, atrial fibrillation, and atrioventricular (AV) block 7, 8 and (ii) expression of RHOA during chicken heart development is ultimately restricted to the sinoatrial node (SAN) and AV node. 9 Supraventricular tachycardias (SVTs) are the most common cardiac arrhythmias in adults and children. 10 SVTs can originate from components of the adult CCS, but also from myocardial structures outside the CCS, such as the pulmonary venous myocardium. 11, 12 To date, mechanisms underlying these pathologies have not been elucidated. Re-expression of embryonic genes or failure to mature so that the embryonic phenotype is retained, however may account for the development of specific arrhythmogenic sites within the heart. 9, 13 In cardiomyopathy, pathophysiological remodelling occurs through reexpression of embryonic genes, 14 a mechanism that could also apply to a specific subset of cardiac arrhythmias. During early development, the heart is initially tubular, but loops and expands through continuous incorporation of cells from the mesoderm dorsal to the heart at the arterial and venous pole. Among the genes expressed by these actively proliferating cell populations is the LIM homeodomain transcription factor Islet1 (Isl1), necessary for proper cellular proliferation, survival, and migration. 15 Isl1 has also been linked to the SAN as a direct downstream target of Shox2 and is able to rescue the bradycardia in Shox2 mutants. 16 Early in development, the initial pacemaker signal originates from the left posterior portion of the venous pole of the heart, 17 later corresponding to the sinus venosus myocardium covering the left cardinal vein. In adults, the SAN is located at the entrance of the right superior caval vein (embryonic right cardinal vein) in the right atrium (RA). Therefore, a shift in pacemaker location from the left towards the right side has to occur. During cardiogenesis, the sinus venosus myocardium covers the developing cardinal veins (adult caval veins) and includes a functional transient left-sided SAN and the definitive right-sided SAN. 9, 18, 19 The developing sinus venosus myocardium, including the SAN, expresses different genes than the atrial and ventricular working myocardium. These include PODOPLANIN, 20 RHOA, 9 Shox2, 16, 21 Tbx18,
22

Tbx3
23
, ISL1, 16 and HCN4 13 but NKX2.5 and connexin (Cx) 40 are absent 24 (reviewed in Ref. 25) . In contrast, atrial and ventricular myocardium does not express Tbx3 or Shox2 but does express NKX2.5. [20] [21] [22] While most of the key players in SAN differentiation have been identified, expression levels within the sinoatrial myocardium of the chicken during heart development are largely unknown. Although the exact mechanism driving restriction of pacemaker function to the right side of the sinus venosus myocardium is unknown, recent studies suggest a role for right/left patterning factors like PITX2C. This gene is linked to a higher susceptibility for atrial arrhythmias 26 and acts as a direct suppressor of Shox2 in the left atrium, inhibiting the SANspecific genetic programme. 18, 27 Based on the evidence linking RHOA to the CCS, [7] [8] [9] we hypothesized that normal RHOA-ROCK signalling is essential for proper formation and differentiation of the SAN during embryonic development. Here, we disrupted ROCK signalling during development of the chicken heart and examined the consequences for gene expression and SAN function. We found that RHOA-ROCK signalling is important in establishing the rightsided SAN as the definitive pacemaker and restricts typical pacemaker gene expression to the right side of the sinus venosus myocardium.
Methods
A detailed description of Experimental Methods used in this study is provided in Supplementary material online.
Rho-signalling disruption, cardiac electrophysiology, and gene expression
Animal experiments were performed in accordance with institutional guidelines of the Leiden University Medical Center. Rho signalling was disrupted by addition of the selective Rho kinase (ROCK) inhibitor compound Y-27632 (688000, Calbiochem, La Jolla, MA, USA) in ovo after 48 h of incubation ( stage HH10/11).2 ml of 100 mM Y-27632 or PBS (as control) was added to the surface of the embryo. A schematic representation of the experimental setup and survival rates of the embryos is provided in Supplementary material online, Figure S1 . Extracellular microelectrode recordings and optical mapping recordings were conducted as described previously. 9, 28 RNA was isolated from control and ROCK inhibited hearts (for HH18-19, whole inflow tract portion were used, from HH20 onwards the inflow tract portion was divided into the right and the left side to assess gene expression separately) and gene expression was analyzed by quantitative Polymerase Chain Reaction (qPCR). Embryos were extracted 24 (stage HH18-19; n = 6 controls (CTRL); n = 8 ROCK inhibition (ROCK)), 48 (stage HH21-22; n = 7 CTRL; n = 9 ROCK), and 96 (stage HH28-29; n = 6 CTRL; n = 8 ROCK) h after treatment. Chicken gene-specific primers designed for the genes of interest are provided in Supplementary material online, Table S1 .
Micro-electrode array (MEA) on isolated chick cardiomyocytes
To study the direct effect of the ROCK inhibitor on rate and amplitude of cardiomyocytes, sinoatrial, atrial, and ventricular cardiomyocytes of stage HH26-27, chicken embryos were cultured as described previously 29 and plated on MEA for electrophysiology. Time point zero was recorded before the ROCK inhibitor Y-27632 was added. Data points are displayed as % relative to time point zero (before application of inhibitory compound).
Patch clamp electrophysiology
Patch clamp electrophysiology was conducted on cardiomyocytes isolated from right/left or whole sinus venosus myocardium and right ventricular myocardium in control and in ovo ROCK-inhibited hearts as previously described. 29 
Results
3.1 Normal SAN development: from broad pacemaking activity to right-sided restriction
Normal development of the SAN in the chicken embryo heart is summarized in Figure 1 . Early in development, just as looping of the heart tube has started (stage HH11), the first sinus venosus myocardium could be observed ventral to the cardinal veins, evidenced by expression of TNNI2 and absence of NKX2.5 ( Figure 1A1-A6) . A cluster of cells at the entrance of the right cardinal vein (superior caval vein in the adult) was the putative right-sided SAN ( Figure 1A1-A3 ), whereas a cluster on the left side reflected the left-sided SAN ( Figure 1A4-A6) . Previously, we showed that at these developmental stages, the sinus venosus myocardium expresses HCN4 mRNA. 13 As the heart continued to grow and loop to adopt its mature four chambered-structure, the sinus venosus expanded considerably ( Figure 1B,C) , still encompassing a right and leftsided SAN. Small differences between right-and left-sided SAN were already evident: the right-sided SAN was more compact than the left (although still had larger intercellular spaces) and showed robust myocardial continuity with the atrial myocardium (compare Figure 1B1 -B3 to B4-B6). At pre-hatching stages (HH42), the right side of the sinus venosus myocardium was the only region lacking NKX2.5 ( Figure 1D ). The fully developed right-sided SAN expressed TNNI2 ( Figure 1D1,D2) , and HCN4 ( Figure 1D4 ) but no NKX2.5 ( Figure 1D3 ). In contrast to earlier stages, the myocardium medial to the left cardinal vein expressed TNNI2 ( Figure 1D5,D6 ) and NKX2.5 ( Figure 1D7 ), whereas HCN4 expression ( Figure 1D8 ) was absent. Thus, although the developing SAN occupied a broad area of the heart early in development, it was restricted to the right side at later stages.
Effect of ROCK inhibition on SAN function: persistent immaturity in function and deficient lateralization
The ability of the entire sinus venosus myocardium to generate the first atrial activation signal has been previously demonstrated. 9, 18, 19 Electrophysiological measurements in the current study confirmed the presence of three atrial activation patterns during development: right side first activation pattern (RA signal precedes left atrium (LA), RA first, Supplementary material online, Figure S2A ,B), left side first (LA signal precedes RA, LA first, Supplementary material online, Figure S2C ,D) and concurrent activation (no distinction can be made between RA or LA (<1 ms difference), Concurrent). These activation patterns were confirmed by optical mapping recordings in which three preferential activation sites were observed: left, middle, and right of the sinus venosus portion of the embryonic heart (Figure 2A-C).
In light of restriction of RHOA expression to the SAN at stage HH28, 9 hearts were divided into two groups for analysis: before (<) and after (> _) HH28. During early stages of normal heart development (<HH28, Figure  2D ), the RA first pattern was observed in 62% (63/95) of the cases, the LA first in 18% (18/95) and the concurrent pattern in 20% (20/95). Later (> _HH28, Figure 2D ), the RA first pattern represented 92% (24/31) of the observed patterns, LA first 4% (1/31) and concurrent 4% (1/31). Longitudinal analysis of activation patterns showed a significant difference between early and late developmental stages (P= 0.014, <HH28 vs. > _HH28), demonstrating a shift towards right-sided pacemaking. At early stages of development (<HH28, Figure 2D ), after ROCK signalling was inhibited, 39% (12/48) of cases showed RA first pattern, 26% (8/ 48) LA first pattern and 35% (11/48) the Concurrent pattern. Differences with controls were not statistically significant (P = 0.061). At later stages (> _HH28, Figure 2A ), ROCK inhibition resulted in 57% (8/18) of RA first cases and 21.5% (3/18) of both LA first and concurrent cases, significantly different (P = 0.03) from the untreated group. Longitudinal analysis revealed no significant difference (P = 0.099) in distribution of atrial activation sites before or after stage HH28 in the ROCK inhibition group.
During normal heart development, pacemaker cell differentiation could be monitored by electrophysiology ex ovo. One of the most striking electrical changes was a significant increase in heart rate in RA first hearts > _HH28 compared with LA first hearts ( Figure 2F ) compared with <HH28 ( Figure 2E ). After ROCK inhibition, the heart rate at late stages (> _HH28) of RA first heart was significantly lower compared with controls ( Figure 2F ). LA first hearts showed a significantly higher heart rate compared with its control counterpart and RA first control hearts ( Figure 2F ). Overall, following ROCK inhibition, more immature activation patterns were observed compared with controls, suggesting that the global pacemaking potential was maintained throughout the sinus venosus myocardium.
Effect of ROCK inhibition on SAN differentiation: hampered lateralization and pacemaker specification
Based on the electrophysiology results, qPCR analysis was conducted on separate right and left portions of the sinoatrial myocardium to assess pacemaker gene expression patterns. The identity of the isolated portions was confirmed by high levels of expression of transcription factors important in SAN differentiation like SHOX2
21
, TBX3, 23 and ISL1
16
, the ion channels necessary for pacemaking HCN4 and HCN1 30, 31 and low levels of the SAN inhibitory transcription factor NKX2.5 24 and gap junction protein Cx 40, highly expressed in atrial myocardium. 18, 27 Early in development, at stage HH21, control hearts showed that nearly all genes studied (i.e. genes of the ROCK pathway, transcription factors important in SAN differentiation) were equally expressed between right-and left-sided sinoatrial myocardium ( Figure 3A ). Significant differences encountered at this stage were higher expression of NKX2.5 (P = 0.0087), TBX5 (P = 0.0159), CX40 (P = 0.0159), CAV3.1 (P = 0.0159), and the left-sided identity gene PITX2C 18, 27 in the left side of the sinoatrial myocardium, as expected (P= 0.0023, Figure 3A) . Later in development, at stage HH29, significant differences between the right and left sides of the sinoatrial myocardium became more apparent ( Figure 3B ). The levels of expression of RHOA, ROCK1, and ROCK2 were significantly lower in the left side. The genetic profile of the inflow tract at HH29 on the right side of this region showed persistent expression of transcription factors and ion channels essential for proper SAN function, whereas the left side showed significantly lower levels of SHOX2 (P = 0.0087), ISL1 (P = 0.0173), TBX3 (P = 0.0079), and HCN4 (P = 0.0022) and significantly higher levels of CX40 (P = 0.0317) and PITX2C (P = 0.0043, Figure 3B ). Thus, functional and morphological changes showed that the definitive pacemaker of the normal heart will be right-sided.
At stage HH21 after ROCK inhibition, expression of ISL1 was significantly higher (P = 0.0401) and TBX3 significantly lower on the left side of the sinus venosus (P = 0.0148, Figure 3C ). At stage HH29 levels of SHOX2 (P = 0.0186), ISL1 (P = 0.0293), PITX2C (P = 0.0007), and CAV3.1 (P = 0.0451) were significantly higher in the left side compared with the right side ( Figure 3D) .
Gene expression levels after ROCK inhibition were compared with control levels. At stage HH21, differences in gene expression levels after ROCK inhibition compared with control became apparent ( Figure 3E ). HCN4 (P = 0.0293) and NKX2.5 (P = 0.0031) levels were lower in the left side, and ISL1 (P = 0.035) and RHOA expression were higher (P = 0.037, Figure 3E ). In the right side, only HCN4 expression was significantly lower (P = 0.0293), while CAV3.1 expression was significantly higher in the right side (P = 0.0079, Figure 3E ). At stage HH29, levels of SHOX2 (P = 0.0173) and ISL1 (P = 0.0079) were significantly higher in the left side, whereas TBX5 (P = 0.0317) and NODAL (P = 0.0043) were significantly lower. In the right side, levels of SHOX2 (P = 0.008), ISL1 (P = 0.02), TBX3 (P = 0.0025), HCN4 (P = 0.0007), and CAV3.1 (P = 0.0451), important for pacemaker development, were low relative to controls. Levels of CX40 (P = 0.0095), normally found in atrial myocardium were high ( Figure 3F ). In accordance with the functional data, after ROCK inhibition, the leftsided SAN region still showed a SAN-like phenotype (explaining the maintained pacemaker functionality in the left side), while the differentiation of the definitive right-sided SAN area was impaired (explaining the decreased heart rate observed in the inhibited hearts). Figure 4C ). In controls, ISL1 expression was restricted to the right-sided SAN at late stages of differentiation ( Figure 3B ,F, compare Figure 4A with Figure 4G ). However, after ROCK inhibition, this ISL1 balance was disrupted. At stage HH26, ROCK inhibition resulted in an overall increase in ISL1þ sinus venosus myocardium, especially in the left portion (compare Figure 4A with B) . This upregulation was still evident at HH29 (compare Figure 4G with H) , supporting the qPCR results ( Figure 3E,F) .
Aberrant sinus venosus differentiation and abnormal pulmonary vein development after ROCK inhibition
Normally, the ISL1þ sinus venosus myocardium is negative for NKX2.5. In accordance with the gene expression analysis, ROCK inhibited hearts showed an increase in ISL1þ/NKX2.5-myocardium on the left side and a decrease on the right side (compare Figure 4D with F) . At HH26, this increase in ISL1þ cells in ROCK-inhibited hearts was also observed in the mesoderm dorsal to heart, where the pulmonary vein is developing (compare Figure 4C with Figure 4E 
The effect of ROCK inhibition on heart rate is specific for the sinoatrial cardiomyocytes
Since ROCK inhibition was applied to the entire heart, we next examined whether effects observed on SAN function and development were specific for this myocardium. MEA experiments were performed on isolated sinoatrial and atrial (only appendages) cells of embryonic chicken hearts HH26-27 of control and ROCK-inhibitor treated groups. Results showed altered heart rate ( Figure 5A ) when ROCK signalling was inhibited in sinoatrial cardiomyocytes but no effect on heart rate in atrial cardiomyocytes ( Figure 5B ). ROCK inhibition did affect signal amplitude in both sinoatrial and atrial cardiomyocytes (see Supplementary material online, Figure 3) . As an internal control, the same experiment was performed on ventricular cardiomyocytes and no effect on rate or amplitude was observed (see Supplementary material online, Figure 4 ). This showed that the effect of inhibiting ROCK signalling was specific for the sinoatrial myocardium including the developing SAN.
ROCK inhibition delays action potential maturation and causes persistent pacemaker potential on the left side
To assess the electrophysiological maturation status of sinus venosus cardiomyocytes after ROCK inhibition, patch clamp electrophysiology was performed at stage HH29 ( Figure 5C-J) . In normal development, maturation of the action potential was observed (compare Figure 5C (stage HH29)) with Figure 5E (stage HH20). After ROCK inhibition, action potential of sinoatrial cardiomyocytes resembled that of HH20 sinoatrial cardiomyocytes more closely than HH29 untreated sinoatrial cardiomyocytes ( Figure 5C-E) . This immaturity was confirmed by a significant decrease in maximal upstroke velocity (dV/dT, P = 0.0035, Figure  5F ), action potential amplitude (P = 0.011, Figure 5H ), and resting membrane potential (P = 0.037, Figure 5J ), which bore more resemblance to early HH20 sinoatrial cardiomyocytes. Right-left sinoatrial differences were also assessed after ROCK inhibition ( Figure 6 ). Immaturity was observed on both right and left-sided sinoatrial cardiomyocytes after ROCK inhibition (Figure 6A-D) . However, after ROCK inhibition, sinoatrial cardiomyocytes from the left side showed characteristics similar to that of the right side (definitive pacemaker), in concordance with the right-sided phenotype observed with qPCR. The action potential duration (APD90) was significantly increased (P= 0.046) and the significant difference with the control group when compared with the right side (P < 0.0001) was no longer apparent (P = 0.307, Figure 6F ). The action potential amplitude was significantly lower on both sides after inhibition (P = 0.014 for right and P < 0.0001 for left, Figure 6G ) and the maximum diastolic potential significantly lower in the left side sinoatrial cardiomyocytes compared with control (P = 0.0016).
Overall, the left-sided sinoatrial cardiomyocytes shared more properties of the right side after ROCK inhibition, indicative of persistent pacemaker potential on the left side.
Discussion
In this study, changes in function and gene expression in the SAN region before full development of the definitive right-sided SAN were described. Rho kinase inhibitors wield a dual effect on the developing SAN. On the one hand, ROCK inhibition results in immaturity of the right-sided SAN and prolonged pacemaker potential of the transient left-sided SAN, reflecting overall immaturity of the sinus venosus myocardium. On the other hand, it results in gap junction and ion channel remodelling of the developing SAN, impairing proper conduction through this myocardium.
ROCK signalling and lateralization of the SAN
Left-right (LR) asymmetry is observed in the entire body plan; establishing this normal asymmetry correctly is essential in determining the position and structure of internal organs, including the heart. Abnormalities in LR asymmetry lead to laterality disorders including complex congenital heart diseases. 32, 33 Asymmetric expression of NODAL, LEFTY, and members of the PITX2 gene family in the lateral plate mesoderm are essential for proper LR-asymmetry. This asymmetry is likely established early in the development by the pre-determined antero-posterior (AP) and dorso-ventral axis in the embryonic plate. 33 Recently, it was demonstrated that RHOA-ROCK signalling is involved in LR-asymmetry. ROCK2B knockdown in zebrafish resulted in abnormal asymmetric gene expression in the lateral plate mesoderm and abnormal LR-patterning in organs. 6 In mouse and chicken, disruption of ROCK signalling using the small molecule inhibitor Y-27632 results in cardiac defects bilateral expression of NODAL in the lateral plate mesoderm in chicken embryos.
3
Although Y-27632 has inhibitory effects on protein kinases other than ROCK1/2, its affinity for Rho kinases is more than 200-fold higher. 3, 34 The present study showed that treatment with Y-27632 resulted in lower levels of ROCK2 expression. However, further research is required to assess whether the effect of Y-27632 on SAN development is exclusively through downregulation of ROCK1/2. Chicken embryos studied here showed abnormal levels of NODAL in the left side of the sinoatrial myocardium. Thus, RHOA-ROCK signalling may play an important role in determining LR-asymmetry early in development, specifically, in establishing right-sidedness in the sinus venosus myocardium, important for proper establishment of the right side SAN as definitive pacemaker of the heart. 38 cardiac differentiation in vitro altering the expression of key genes in early cardiac lineages like GATA4, ISL1, and TBX5. 5, 38 In our study, at late developmental stages, low levels of ROCK1
and ROCK2 in the right portion of the sinoatrial myocardium were accompanied by low levels of expression of key transcription factors necessary for proper SAN differentiation (ISL1, SHOX2, TBX3, and HCN4, Figure 3 ). Myocardial transcriptional targets of the RHOA-ROCK pathway are SRF, GATA4, a-ACTIN, TBX5, and ISL1. expression has yet to be discovered. The dysregulation of ISL1 expression is observed in both the myocardial (TNNI2þ) and the TNNI2-cell population dorsal to the heart. The expression of Isl1 in the developing SAN (i.e. the myocardial population) is important for proper SAN differentiation 37 and function. 16 Putative binding sites for Isl1 were identified within the regulatory regions of Tbx3 and Hcn4, suggesting a novel regulatory function of Isl1 within the SAN gene program.
37
ISL1 expression in the mesenchymal population is important for normal pulmonary vein development. 39 This is interesting in the light of the arrhythmogenic potential attributed to the pulmonary venous myocardial sleeves, as well as the potential involvement of the RHOA-ROCK signalling pathway in anomalous pulmonary venous connections. 12 A well-kept Shox2 and Nkx2.5 balance has recently been described as the mechanism that ensures the non-pacemaker phenotype of the pulmonary venous myocardial sleeve during development. 40 In this study, SHOX2 and ISL1 are abnormally expressed in the venous pole of the heart, potentially leading to an increased arrhythmogenic potential due to abnormal/insufficient differentiation. To ensure coordination between propagation of the pacemaking signal and contraction of the chambers, electrical heterogeneity of the myocardium is required. This is accomplished by differential expression of Cx and ion channels within the chambers. 41 For instance, high levels of Cx40 expression in the atrial myocardium ensure rapid propagation of the electrical impulse from the SAN to allow for simultaneous atrial contraction. 21, 24, 27 The abnormal conduction through the sinus venosus myocardium found in this study could be due to the effect of RHOA-ROCK signalling on ion channel expression or activity. This could account for the electrophysiological differences observed in SAN electrophysiology between whole-heart and single cell measurements. Altered Rho-signalling has been associated with abnormalities in expression of Cx40 8 and 43, 42 and L-type Ca2þ channels, 43 The expression of Cx40 was altered after Rho-kinase inhibition, resulting in high expression in the right-sided SAN ( Figure 3 ). In the chick heart, the expression of connexins (40, 43, and 45 ) is different than in mammals. 44 The expression of all three connexins was studied but only Cx40 is of relevance in the developing chick SAN. Given the direct regulatory role of the RHOA-ROCK pathway on Cx43 expression in myocardial cells, this pathway could be involved in regulating Cx40 expression during development. In the mouse heart, L-type Cav1.2 and T-type Cav3.1 Ca2þ channels are highly expressed in the SAN. 45 Since RHOA has been found to regulate L-type Ca2þ currents in ventricular cardiomyocytes 43 and mice lacking T-type Cav3.1 Ca2þ channels show bradycardia, 45 we studied its expression pattern in the developing SAN and the effects of ROCK inhibition. After ROCK inhibition, expression levels of Cav3.1 were altered, specifically in the right-sided SAN ( Figure  3) . Additional experiments are necessary to unravel the mechanism by which RHOA can regulate Cav3.1 expression and/or activity, as observed in ventricular cardiomyocytes for Cav1.2. 
RHOA-ROCK signalling in human disease
Human genetic studies have linked abnormal RHOA-ROCK signalling with several congenital heart abnormalities. Specifically, low-frequency variants in the ROCK1 gene have been associated with a higher risk of developing Tetralogy of Fallot. 46 Mutations in the protein phosphatase SHP-2 have been linked to Noonan and Leopard syndrome, both frequently associated with congenital heart abnormalities like pulmonary valve stenosis, hypertrophic cardiomyopathy, or conduction abnormalities. Missense mutations in SHP-2 in these patients cause hyperactivation of the RHOA-ROCK pathway. 47 Additionally, trisomy 18 and 21 foetuses show higher levels of ROCK1 RNA, and the ROCK1 gene is located on chromosome 18 in humans. 48 RHOA was found to regulate Cx43 expression providing a plausible disease mechanism for these patients. 42 These data suggest a role for RHOA-ROCK signalling in human cardiac diseases. Overall RHOA-ROCK signalling is essential for establishing the rightsided SAN as definitive pacemaker of the adult heart. Abnormal RHOA-ROCK signalling results in an immature sinus venosus myocardium including the SAN and ectopic maintenance of a pacemaker phenotype in the left-sided sinus venosus.
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